Immunoglobulins: Optimizing Immunoglobulin Use for Immune Disorder Treatment (IV vs SQ options)
New Orleans, LA US
January 23, 2020
This activity will address this need by providing background information and insight into why patient-centered immunoglobulin use is important. We will also outline currently available immunoglobulin products and how they vary. Additionally, this activity will provide further knowledge into specifics of how product formulations vary and how to prevent adverse effects while still achieving desired clinical outcomes. This will assist with effective management of patient data. Lastly, the activity will create an opportunity to discuss practical ways we can improve product selection in practice.
Target Audience
- Pharmacists
- Pharmacy technicians
Learning Objectives
Pharmacist learning objectives
- Discuss the differences amongst commercially available immunoglobulin products
- Examine various formulations of immunoglobulin products and how composition and adverse effects vary
- Analyze the differences in subcutaneous versus intravenous administration
Pharmacy technician objectives
- Discuss the differences amongst commercially available immunoglobulin products
- Define immune disorder
Additional Information
Attachment | Size |
---|---|
![]() | 23.3 KB |
Ochsner Medical Center
1514 Jefferson Hwy.
New Orleans, LA
70121
United States
Relevant financial relationships: Planning committee members and the presenter have nothing to disclose
Planning committee members
Sheena Babin, PharmD, CSP
Pharmacist
Ochsner Medical Center
Kathleen Romero, PharmD, BCACP
Pharmacist
Ochsner Medical Center
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, DPLA
Pharmacy Clinical Director
Vizient
Presenter
T’Keyah Z. Bazin, PharmD
Pharmacy – PGY1 Resident
Ochsner Medical Center

Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
Designation Statements:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-028-L01-P
Universal Activity Number: JA0006103-9999-20-028-L01-T
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CEU – Attendance